CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium

European Respiratory Journal

Volumn 42, Issue 6, 2013, Pages 1553-1562

  Martin, Clémence ^a,b   Coolen, Nathalie ^a,b   Wu, Yongzheng ^c,d   Thévenot, Guiti ^a   Touqui, Lhousseine ^c,d   Prulière Escabasse, Virginie ^e,f   Papon, Jean François ^e,f   Coste, André ^e,f   Escudier, Estelle ^g,h   Dusser, Daniel J ^a,b   Fajac, Isabelle ^a,b   Burgel, Pierre Régis ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b université Paris Cité   (France)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

^e CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^f INSERM U955   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

^h Assistance publique Hôpitaux de Paris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPIDERMAL GROWTH FACTOR RECEPTOR; SMALL INTERFERING RNA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG BLOOD VESSEL; MORPHOMETRICS; MOUSE; NONHUMAN; PERIBRONCHIAL ANGIOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RESPIRATORY EPITHELIUM; UPREGULATION; WILD TYPE;

ANIMALS; AORTA; BRONCHI; CELL LINE; CELLS, CULTURED; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIUM; GENE EXPRESSION REGULATION; HUMANS; LUNG; MICE; MICE, INBRED CFTR; MICE, TRANSGENIC; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; TRACHEA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890011741     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00164212     Document Type: Article

References (41)

1. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373: 1891-1904.
2. Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 2012; 18: 509-519.
3. Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med 2011; 183: 1463-1471.
4. Burgel PR, Montani D, Danel C, et al. A morphometric study of mucins and small airway plugging in cystic fibrosis. Thorax 2007; 62: 153-161.
5. Hays SR, Ferrando RE, Carter R, et al. Structural changes to airway smooth muscle in cystic fibrosis. Thorax 2005; 60: 226-228.
6. Regamey N, Jeffery PK, Alton EW, et al. Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax 2011; 66: 624-629.
7. McCullagh A, Rosenthal M, Wanner A, et al. The bronchial circulation - worth a closer look: a review of the relationship between the bronchial vasculature and airway inflammation. Pediatr Pulmonol 2010; 45: 1-13.
8. Paredi P, Barnes PJ. The airway vasculature: recent advances and clinical implications. Thorax 2009; 64: 444-450.
9. Danese S, Dejana E, Fiocchi C. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 2007; 178: 6017-6022.
10. Frantz S, Vincent KA, Feron O, et al. Innate immunity and angiogenesis. Circ Res 2005; 96: 15-26.
11. Baluk P, Lee CG, Link H, et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial factor in airways. Am J Pathol 2004; 165: 1071-1085.
12. McColley SA, Stellmach V, Boas SR, et al. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 2000; 161: 1877-1880.
13. Meyer KC, Cardoni A, Xiang ZZ. Vasular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 2000; 135: 332-338.
14. Watts KD, McColley SA. Elevated vascular endothelial growth factor is correlated with elevated erythropoietin in stable young cystic fibrosis patients. Pediatr Pulmonol 2011; 46: 683-687.
15. Krenn K, Klepetko W, Taghavi S, et al. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation. Eur J Cardiothorac Surg 2007; 32: 35-41.
16. Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science 1992; 257: 1083-1088.
17. French PJ, van Doorninck JH, Peters RH, et al. A DF508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J Clin Invest 1996; 98: 1304-1312.
18. Martin C, Thévenot G, Danel S, et al. Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J 2011; 38: 939-946.
19. Hsia CC, Hyde DM, Ochs M, et al. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 2010; 181: 394-418.
20. Nagayama S, Kai H, Okiyoneda T, et al. Characterization of CFTR expression in a human pulmonary mucoepidermoid carcinoma cell line, NCI-H292 cells. FEBS lett 1999; 455: 215-218.
21. Coste A, Brugel L, Maitre B, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 2000; 15: 367-372.
22. Papon JF, Coste A, Gendron MC, et al. HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps. Laryngoscope 2002; 112: 2067-2075.
23. Prulière-Escabasse V, Fanen P, Dazy AC, et al. TGF-beta 1 downregulates CFTR expression and function in nasal polyps of non-CF patients. Am J Physiol Lung Cell Mol Physiol 2005; 288: L77-L83.
24. Ma T, Thiagarajah JR, Yang H, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 2002; 110: 1651-1658.
25. Tradtrantip L, Sonawane ND, Namkung W, et al. Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model. J Med Chem 2009; 52: 6447-6455.
26. Perez A, Issler AC, Cotton CU, et al. CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung Cell Mol Physiol 2007; 292: L383-L395.
27. Dif F, Wu YZ, Burgel PR, et al. Critical role of cytosolic phospholipase A2a in bronchial mucus hypersecretion in CFTR-deficient mice. Eur Respir J 2010; 36: 1120-1130.
28. Burgel PR, Lazarus SC, Tam DCW, et al. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor activation. J Immunol 2001; 167: 5948-5954.
29. Koff JL, Shao MX, Ueki IF, et al. Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol 2008; 294: L1068-L1075.
30. Verhaeghe C, Tabruyn SP, Oury C, et al. Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 2007; 356: 745-749.
31. Machen TE. Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol 2006; 291: C218-C230.
32. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473: 298-307.
33. Lee HS, Myers A, Kim J. Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis. Am J Respir Crit Care Med 2009; 180: 1056-1067.
34. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107: 295-301.
35. Wilke M, Buijs-Offerman RM, Aarbiou J, et al. Mouse models of cystic fibrosis: phenotypic analysis and research applications. J Cyst Fibrosis 2011; 10: Suppl. 2, S152-S171.
36. Kim SR, Lee KS, Park HS, et al. HIF-1a inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium. Eur J Immunol 2010; 40: 2858-2869.
37. Tyner JW, Kim EY, Ide K, et al. Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest 2006; 116: 309-321.
38. Takeyama K, Fahy JV, Nadel JA. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med, 163: 511-516.
39. Flume PA, Yankaskas JR, Ebeling M, et al. Massive hemoptysis in cystic fibrosis. Chest 2005; 128: 729-738.
40. Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365: 1663-1672.
41. Rogan MP, Stoltz DA, Hornick DB. Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment. Chest 2011; 139: 1480-1490.